Veru Inc Total Liabilities
Veru Inc total liabilities. Based on the latest financial reports, Veru Inc (VERU) has total liabilities worth $10.44 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check VERU asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Veru Inc (1990–2025)
Total liabilities of Veru Inc from 1990 to 2025. This chart illustrates how Veru Inc's total liabilities have evolved over time, based on quarterly financial data. Explore VERU long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Veru Inc Competitors by Total Liabilities
The table below lists competitors of Veru Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GeneFerm Biotechnology Co Ltd
TWO:1796
|
Taiwan | NT$453.10 Million |
|
Vardhman Acrylics Limited
NSE:VARDHACRLC
|
India | Rs-2.54 Billion |
|
Mr Bricolage
PA:ALMRB
|
France | €207.68 Million |
|
Co2 Capsol AS
OL:CAPSL
|
Norway | Nkr42.19 Million |
|
Liberty Shoes Limited
NSE:LIBERTSHOE
|
India | Rs2.83 Billion |
|
Neofect Co.Ltd
KQ:290660
|
Korea | ₩24.18 Billion |
|
Reino Capital SA
WAR:RNC
|
Poland | zł36.69 Million |
|
JASTECH Ltd
KQ:090470
|
Korea | ₩121.47 Billion |
Liability Composition Analysis (1990–2025)
This chart breaks down Veru Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Veru Inc asset portfolio.
Liquidity & Leverage Metrics
Veru Inc Total Liabilities Ratios Explained
Veru Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Veru Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Veru Inc (1990–2025)
The table below shows the annual total liabilities of Veru Inc from 1990 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $11.50 Million | -59.07% |
| 2024-09-30 | $28.10 Million | -7.39% |
| 2023-09-30 | $30.34 Million | -42.27% |
| 2022-09-30 | $52.56 Million | +103.31% |
| 2021-09-30 | $25.85 Million | +20.62% |
| 2020-09-30 | $21.43 Million | +0.64% |
| 2019-09-30 | $21.30 Million | +12.25% |
| 2018-09-30 | $18.97 Million | +176.82% |
| 2017-09-30 | $6.85 Million | +46.11% |
| 2016-09-30 | $4.69 Million | +8.10% |
| 2015-09-30 | $4.34 Million | +20.26% |
| 2014-09-30 | $3.61 Million | -4.23% |
| 2013-09-30 | $3.77 Million | -39.52% |
| 2012-09-30 | $6.23 Million | +131.52% |
| 2011-09-30 | $2.69 Million | +20.31% |
| 2010-09-30 | $2.24 Million | -59.97% |
| 2009-09-30 | $5.59 Million | +35.53% |
| 2008-09-30 | $4.12 Million | +10.02% |
| 2007-09-30 | $3.75 Million | +40.12% |
| 2006-09-30 | $2.67 Million | +12.84% |
| 2005-09-30 | $2.37 Million | -11.26% |
| 2004-09-30 | $2.67 Million | -41.22% |
| 2003-09-30 | $4.54 Million | -7.91% |
| 2002-09-30 | $4.93 Million | +15.29% |
| 2001-09-30 | $4.28 Million | -11.12% |
| 2000-09-30 | $4.81 Million | +0.62% |
| 1999-09-30 | $4.78 Million | +3.46% |
| 1998-09-30 | $4.62 Million | -3.35% |
| 1997-09-30 | $4.78 Million | -22.67% |
| 1996-09-30 | $6.19 Million | -0.20% |
| 1995-09-30 | $6.20 Million | +5.08% |
| 1994-09-30 | $5.90 Million | +1.72% |
| 1993-09-30 | $5.80 Million | +26.09% |
| 1992-09-30 | $4.60 Million | +31.43% |
| 1991-09-30 | $3.50 Million | +16.67% |
| 1990-09-30 | $3.00 Million | -- |
About Veru Inc
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosa… Read more